netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Results

Looking for Olaparib found 7 matches
Open monograph to display formulary status BNF Category
  Cytotoxic Drug Olaparib  (Lynparza®) Malignant disease and immunosuppression - Other antineoplastic drugs - 08.01.05
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section NICE TA886: Olaparib for adjuvant treatment of BRCA mutation-positive HER2-negative high-risk early breast cancer after chemotherapy (08.01.05)
link in drug section NICE TA887: Olaparib for previously treated BRCA mutation-positive hormone-relapsed metastatic prostate cancer (08.01.05)
link in drug section NICE TA908: Olaparib for maintenance treatment of relapsed, platinum-sensitive ovarian, fallopian tube or peritoneal cancer after 2 or more courses of platinum-based chemotherapy (08.01.05)
link in drug section NICE TA946: Olaparib with bevacizumab for maintenance treatment of advanced high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer (08.01.05)
link in drug section NICE TA951: Olaparib with abiraterone for untreated hormone-relapsed metastatic prostate cancer (08.01.05)
link in drug section NICE TA962: Olaparib for maintenance treatment of BRCA mutation-positive advanced ovarian, fallopian tube or peritoneal cancer after response to first-line platinum-based chemotherapy (08.01.05)


 
netFormulary